Researcher and developer, specializing in the study of the crystal structure of biologically active materials. The institute's research focuses on finding treatments for cancer, hypertension, heart disease, diabetes, atherosclerosis, thyroid disease, and AIDS. The institute also provides grant and research funds to related institutions. The bulk of revenue is derived from activity in the pharmaceuticals industry. This company was capitalized by private investment. No international business reported. Products include hypertension medication R&D, diabetes medication R&D, thyroid disease medication R&D, atherosclerosis medication R&D, heart disease medication R&D, cancer treatment R&D, aIDS medication R&D.